Hjem › Plateepitelcancer i hode og hals › Connecticut › New Haven
Kliniske studier for Plateepitelcancer i hode og hals i New Haven, CT
22 studier for Plateepitelcancer i hode og hals søker deltakere på steder i og rundt New Haven (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekruttererFase 1
- Exelixis Clinical Site #62, New Haven
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RekruttererFase 1
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
RekruttererFase 1
- Yale University - Yale University School of Medicine, New Haven
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
RekruttererFase 3
- Yale Cancer Center, New Haven
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
RekruttererFase 1/2
- Yale Cancer Center, New Haven
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
RekruttererFase 2
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekruttererFase 1
- Yale University, Yale Cancer Center, New Haven
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RekruttererFase 2
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 mi unna
- og 1 flere
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
RekruttererFase 1/2
- Yale Cancer Center, New Haven
ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
RekruttererFase 1
- Yale University Cancer Center, New Haven
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RekruttererFase 1
- Normunity Investigational Site, New Haven
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
RekruttererFase 2/3
- Yale University, New Haven
CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs
RekruttererFase 2Frivillige helsepersonell ønskes velkommen
- Yale University, New Haven
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
RekruttererFase 1/2
- Yale Comprehensive Cancer Center, New Haven
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- Yale University, Yale Cancer Center, New Haven
5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC
RekruttererFase 2
- Yale University, New Haven
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
RekruttererFase 1
- Yale University School of Medicine /ID# 225707, New Haven
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
RekruttererFase 3
- GSK Investigational Site, New Haven
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
RekruttererFase 3
- Yale School of Medicine - Smilow Cancer Hospital, New Haven
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
RekruttererFase 1/2
- Yale Cancer Center, New Haven
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
RekruttererFase 1/2
- Yale Cancer Center, New Haven
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
RekruttererFase 2
- Yale, New Haven
Plateepitelcancer i hode og hals-studier i andre byer
- Houston, TX47 studier
- Los Angeles, CA42 studier
- Boston, MA40 studier
- New York City, NY39 studier
- Nashville, TN39 studier
- St. Louis, MO28 studier
- Arlington, VA26 studier
- Philadelphia, PA26 studier
- Chicago, IL26 studier
- Atlanta, GA24 studier
- San Antonio, TX22 studier
- Pittsburgh, PA22 studier
Andre studier i New Haven
- Ikke-småcellet lungekreft41 studier
- Brystkreft38 studier
- Kreft (alle typer)33 studier
- Metastatisk kreft23 studier
- Lungekreft22 studier
- Eggstokkreft21 studier
- Kolorektal kreft20 studier
- Prostatakreft20 studier
- Akut myelogen leukemi17 studier
- Alkoholbrukforstyrrelse (AUD)17 studier
- Opioidoverdose17 studier
- Pankreaskreft16 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.